ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Drugs-WHO and Multinationals

WHO and Multinationals A Correspondent writes. THE unofficial, informal links between multinational corporations and some UN agencies have long been debated. The ICP (Industry Co-operative Programme) within the FAO was a prime example, and had to be dismantled once the links were discovered by action groups. On the other hand, the WHO prescription for a rational drug policy is well known, has been recommended for all countries, developed and underdeveloped, and is often adduced as proof of the WHO's neutrality. Its principal contribution has been the selection of a list of essential drugs numbering 250, which the WHO has suggested are more than adequate for a population's basic health programmes, a list of course, that has not enamoured the WHO to the drug multinationals.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now


(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top